AI assistant
Sending…
REGENXBIO Inc. — Director's Dealing 2017
Sep 7, 2017
32827_dirs_2017-09-07_1d804793-78fb-4d1d-b0b6-0f4a68423bde.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: REGENXBIO Inc. (RGNX)
CIK: 0001590877
Period of Report: 2017-09-05
Reporting Person: Mills Kenneth T. (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-09-05 | Common Stock | S | 10500.00 | $25.00 | Disposed | 118530.00 | Direct |
Footnotes
F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan.
More from REGENXBIO Inc.
Merger & Acquisition
2026
Jun 3
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 3
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
May 14
Proxy Solicitation & Information Statement
2026
Apr 14
Regulatory Filings
2026
Mar 20
Regulatory Filings
2026
Feb 10
Director's Dealing
2026
Feb 3
Director's Dealing
2026
Feb 3
Director's Dealing
2026
Jan 29